Sandu Pharma. VS Pharmaceuticals & Biotechnology 
1D
0%
-0.36%
1W
1.45%
-0.21%
1M
-2.93%
0.89%
YTD
6.33%
-8.16%
1Y
-19.84%
-2.9%
3Y
-28.21%
19.81%
5Y
-17.68%
43.53%
10Y
28.39%
180.92%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (2.03%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.0%
0%
2.0%
6 Months
13.55%
0%
13.55%
1 Year
-19.84%
1.60%
-18.24%
2 Years
-31.99%
2.53%
-29.46%
3 Years
-28.21%
4.05%
-24.16%
4 Years
-39.7%
4.55%
-35.15%
5 Years
-17.68%
7.08%
-10.6%
Latest dividend: 0.7999999999999999 per share ex-dividend date: Sep-18-2025
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Sandu Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods
4
Quartile
QTD
-2.93%
2
Quartile
Mar-Jun
34.34%
2
Quartile
Dec-Mar
-18.46%
2
Quartile
YTD
-20.4%
1
Quartile
2025
-34.63%
4
Quartile
2024
-15.92%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Sandu Pharmaceuticals Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
2
Quartile
QTD
-2.93%
1
Quartile
Mar-Jun
34.34%
2
Quartile
Dec-Mar
-18.46%
3
Quartile
YTD
-20.4%
3
Quartile
2025
-34.63%
4
Quartile
2024
-15.92%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXRisk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
